Clinical Trials Browser

Phase 1/2 × Inflammatory Breast Neoplasms × Lapatinib × Clear all

NCT00450892 2016-07-07

Phase I/II Study of Neoadjuvant Lapatinib in Breast Cancer

Phase 1/2 Completed

Breast Neoplasms, Inflammatory Breast Neoplasms